Smoking increases the risk of multiple sclerosis in Queensland, Australia

Journal of Clinical Neuroscience

Volumn 21, Issue 10, 2014, Pages 1730-1733

  O'Gorman, C ^a,c   Bukhari, W ^a   Todd, A ^b   Freeman, S ^a   Broadley, S A ^a,b  

^a GRIFFITH UNIVERSITY   (Australia)

^b GOLD COAST UNIVERSITY HOSPITAL   (Australia)

^c MAYO CLINIC   (United States)

Author keywords

Case control studies; Multiple sclerosis; Risk factors in epidemiology

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ETHNICITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; GENDER; HUMAN; INTERMEDIATE RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; MIDDLE AGED; REGRESSION ANALYSIS; RISK;

CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; ODDS RATIO; QUEENSLAND; REGRESSION ANALYSIS; RISK; SMOKING;

EID: 84908500169     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2014.01.009     Document Type: Article

References (32)

1. Compston A, Coles A. Multiple sclerosis. Lancet 2008;372:1502-17.
2. O'Gorman C, Lin R, Stankovich J, et al. Modelling genetic susceptibility to multiple sclerosis with family data. Neuroepidemiology 2013;40:1-12.
3. Handel AE, Williamson AJ, Disanto G, et al. Smoking and multiple sclerosis: an updated meta-analysis. PloS One 2011;6:e16149.
4. Handel AE, Williamson AJ, Disanto G, et al. An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PloS One 2010;5:e12496.
5. Munger KL, Zhang SM, O'Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004;62:60-5.
6. Islam T, Gauderman WJ, Cozen W, et al. Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins. Neurology 2007;69:381-8.
7. Hammond SR, McLeod JG, Millingen KS, et al. The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. Brain 1988;111:1-25.
8. White V, Hill D, Siahpush M, et al. How has the prevalence of cigarette smoking changed among Australian adults? Trends in smoking prevalence between 1980 and 2001. Tobacco Control 2003;12. ii67-74.
9. Simon KC, van der Mei IA, Munger KL, et al. Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1∗1501 on multiple sclerosis risk. Neurology 2010;74:1365-71.
10. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005;58:840-6.
11. Kurtzke JF. Rating neurologic impairment in multiple sclerosis. An expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
12. Lechner-Scott J, Kappos L, Hofman M, et al. Can the expanded disability status scale be assessed by telephone? Mult Scler 2003;9:154-9.
13. IBM SPSS Statistics for Windows [program]. 21.0 version. Armonk, NY; 2012.
14. Robertson N, Deans J, Fraser M, et al. Multiple sclerosis in the north Cambridgeshire districts of East Anglia. J. Neurol. Neurosurg. Psychiatry 1995;59:71-6.
15. Services USDoHaH. Preventing tobacco use among young people. A report of the Surgeon General: U.S. Department of health and human services. Public Health Service, Centers of Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1994.
16. Edwards P, Roberts I, Clark M, et al. Methods to increase response rates to postal questionnaires. Cochrane Database Syst Rev 2007;2:MR000008.
17. Wilson A, Manku-Scott T, Shepherd D, et al. A comparison of individual and population smoking data from a postal survey and general practice records. Br J Gen Pract 2000;50:465-8.
18. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham study. Am Heart J 1987;113:1006-10.
19. Stefanick ML, Legault C, Tracy RP, et al. Distribution and correlates of plasma fibrinogen in middle-aged women. Initial findings of the Postmenopausal Estrogen/Progestin Interventions (PEPI) study. Arterioscler Thromb Vasc Biol 1995;15:2085-93.
20. Tracy RP, Psaty BM, Macy E, et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol 1997;17:2167-76.
21. Bermudez EA, Rifai N, Buring J, et al. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 2002;22:1668-73.
22. Pearce MS, Ahmed A, Tennant PW, et al. Lifecourse predictors of adult fibrinogen levels: the Newcastle Thousand Families Study. Int J Cardiol 2012;155:206-11.
23. Graham NM. The epidemiology of acute respiratory infections in children and adults: a global perspective. Epidemiol Rev 1990;12:149-78.
24. Makrygiannakis D, Hermansson M, Ulfgren AK, et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008;67:1488-92.
25. Harkiolaki M, Holmes SL, Svendsen P, et al. T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. Immunity 2009;30:348-57.
26. Mitrovic B, Ignarro LJ, Vinters HV, et al. Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience 1995;65:531-9.
27. Mitrovic B, Parkinson J, Merrill JE. An in vitro model of oligodendrocyte destruction by Nitric oxide and its relevance to multiple sclerosis. Methods 1996;10:501-13.
28. Smith KJ, Kapoor R, Felts PA. Demyelination: the role of reactive oxygen and Nitrogen species. Brain Pathol 1999;9:69-92.
29. Marrie RA, Horwitz R, Cutter G, et al. High frequency of adverse health behaviors in multiple sclerosis. Mult Scler 2009;15:105-13.
30. Schierbeck LL, Rejnmark L, Tofteng CL, et al. Vitamin D deficiency in postmenopausal, healthy women predicts increased cardiovascular events: a 16-year follow-up study. Eur J Endocrinol 2012;167:553-60.
31. Morabia A, Bernstein MS, Antonini S. Smoking, dietary calcium and vitamin D deficiency in women: a population-based study. Eur J Clin Nutr 2000;54:684-9.
32. Daly RM, Gagnon C, Lu ZX, et al. Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study. Clin Endocrinol (Oxf) 2012;77:26-35.